From: Impact of oocytes with CLCG on ICSI outcomes and their potential relation to pesticide exposure
LCLCG (n = 83) |
HCLCG (n = 68) | p-value | ||
---|---|---|---|---|
Total number of oocytes | 1178 | 943 | - | |
Oocytes per patient | 14.1 ± 5.7 | 13.6 ± 5.5 | ns | |
MII per patient | 10.4 ± 4.1 | 9.4 ± 4.2 | ns | |
Maturation rate (%) |
(868/1178) 74% |
(653/943) 69% | ns | |
Embryological outcomes | Fertilization rate (%) |
(577/868) 66% |
(388/653) 59% | ns |
Cleavage rate (%) |
(576/577) 99% |
(321/388) 82% | 0.04 (s) | |
Best embryo quality (A + B) rate (%) |
(358/576) 62% |
(200/321) 62% | ns | |
Embryo cryopreservation rate (%) |
(150/423) 35% |
(78/211) 37% | ns | |
Cryopreserved embryos per patient | 1.8 ± 0.5 | 1.2 ± 0.7 | 0.01 (s) | |
Total number oftransferredembryos | 153 | 110 | - | |
Transferred embryos per patient | 1.9 ± 0.8 | 1.6 ± 1 | ns | |
Total embryo transfer cycles | 79 | 55 | - | |
Clinical outcomes | Clinical pregnancy rate (%) |
(28/79) 35% |
(15/55) 27% | ns |
Early miscarriage rate (%) |
(3/28) 11% |
(7/15) 47% | 0.01 (s) | |
Ongoing pregnancy rate (%) |
(25/79) 32% |
(8/55) 14% | 0.01 (s) | |
Late miscarriage rate (%) |
(1/25) 4% |
(1/8) 12% | 0.02 (s) | |
Live birth rate (%) |
(24/79) 30% |
(7/55) 13% | 0.01 (s) |